France Pharmaceuticals & Healthcare Q1 2021

France Pharmaceuticals & Healthcare Q1 2021

Key View:

France's pharmaceutical industry has continued to demonstrate robust research and productive capacity throughoutthe pandemic, with several local multinationals throwing considerable resources behind Covid-19 vaccine development. Despitethis, the previous months have exposed an overreliance on Asia for its pharmaceutical supply chains, an issue that will needrebalancing going forward. Further, an above-average number of coronavirus infections amid the second wave has put additionalstrain on the healthcare system and prompted further industrial action from health workers.


Key View
France Pharmaceuticals & Healthcare Covid-19 Impact
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Innovative Pharmaceuticals Risk/Reward Index
Innovative Risk/Reward Index
Regulatory Development
Market Overview
Competitive Landscape
Company Profile
GlaxoSmithKline
Ipsen
Merck & Co
Novartis
Sanofi
Servier
France Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook